Active Ingredient: ARIPIPRAZOLE
Proprietary Name: ABILIFY ASIMTUFII
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 960MG/3.2ML (300MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217006
Product Number: 002
Approval Date: Apr 27, 2023
Applicant Holder Full Name: OTSUKA PHARMACEUTICAL CO LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
